US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Seaport Therapeutics

21.75

-2.3100-9.60%

Volume:316.78K

Turnover:7.46M

Market Cap:1.16B

PE:-8.64

High:25.52

Open:24.14

Low:21.73

Close:24.06

52wk High:28.38

52wk Low:14.85

Shares:53.53M

Float Shares:14.16M

Volume Ratio:2.59

T/O Rate:2.24%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5160

EPS(LYR):-10.0430

ROE:-28.08%

ROA:-18.90%

PB:2.76

PE(LYR):-2.17

Loading ...

Overview Company News Filings

Seaport Therapeutics Q2 EPS $(1.78) Misses $(0.65) Estimate

Benzinga Earnings

Seaport Therapeutics Q2 FY26 Net Loss Widens to $62.6 Million; R&D Expenses Rise to $24.62 Million

Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

THOMSON REUTERS

Seaport Therapeutics Initiated at Buy by HC Wainwright & Co.

Seaport Therapeutics, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $50

THOMSON REUTERS

Seaport Therapeutics participates in a conference call with JPMorgan

Top Insider Just Boosted Stake in Seaport Therapeutics With a Bold Buy

Seaport Therapeutics Director Robert J. Hombach Trust Buys 13,000 Shares Worth $235,768

Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)

Seaport Therapeutics Q1 Net Loss Widens

MT Newswires Live

Seaport Therapeutics Q1 EPS $(10.34) Misses $(9.48) Estimate

Benzinga Earnings

Seaport Therapeutics reports Q1 EPS ($10.34) vs. ($5.65) last year

Seaport Therapeutics sees cash runway into 2029

Earnings Flash (SPTX) Seaport Therapeutics Posts Q1 Net Loss $10.34 a Share, vs. FactSet Est of $10.64 Loss

MT Newswires Live

Seaport Therapeutics - Q1 Net Loss per Share $10.34

THOMSON REUTERS

Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

THOMSON REUTERS

Seaport Therapeutics - Seven-Day Glyphago Dosing Achieves Therapeutic Agomelatine Exposures Without Liver Enzyme Elevations

THOMSON REUTERS

Seaport Therapeutics - to Initiate Phase 2B Glyphago Trial in First Half of 2027

THOMSON REUTERS

Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data From Phase 1 Proof-of-Concept Trial of Glyphago™ in Healthy Volunteers

THOMSON REUTERS

Seaport Therapeutics - Repeat Dosing of Glyphago Shows Favorable Safety and No Liver-Related Adverse Events

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/SPTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SPTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPTX\",,,,,undefined,":{"symbol":"SPTX","market":"US","secType":"STK","nameCN":"Seaport Therapeutics","latestPrice":21.75,"timestamp":1788984000000,"preClose":24.06,"halted":0,"volume":316780,"delay":0,"changeRate":-0.09600997506234409,"floatShares":14160000,"shares":53530550,"eps":-2.516,"marketStatus":"Pre-Mkt","change":-2.31,"latestTime":"09-10 07:00:17 EDT","open":24.14,"high":25.52,"low":21.73,"amount":7461496.94176,"amplitude":0.157523,"askPrice":21.75,"askSize":100,"bidPrice":20.6,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.516,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":1,"adr":0,"listingDate":1777608000000,"exchange":"NASDAQ","adjPreClose":21.75,"postHourTrading":{"tag":"盘后","latestPrice":21.75,"preClose":21.75,"latestTime":"19:30 EDT","volume":1215,"amount":26426.25,"timestamp":1788996608005,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.590395635860922},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPTX\",,,,,undefined,":{"symbol":"SPTX","floatShares":14160000,"roa":"-18.90%","roe":"-28.08%","lyrEps":-10.043037,"volumeRatio":2.590395635860922,"shares":53530550,"dividePrice":0,"high":25.52,"amplitude":0.157523,"preClose":24.06,"low":21.73,"week52Low":14.85,"pbRate":"2.76","week52High":28.3833,"institutionHeld":0,"latestPrice":21.75,"eps":-2.516,"divideRate":0,"volume":316780,"delay":0,"ttmEps":-2.516,"open":24.14,"prevYearClose":18,"prevWeekClose":24.86,"prevMonthClose":23.68,"prevQuarterClose":21.72,"fiveDayClose":23.61,"twentyDayClose":23.36,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-03","symbol":"SPTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.71,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785729600000,"reportTimeType":"pre","actualEps":-1.78}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.4286,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":7,"updateTime":1787716800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPTX","date":"2026-09-09","current":-8.644674,"percent":0.896552,"low":-14.505892,"twenty":-12.770979,"median":-11.992093,"eighty":-9.888409,"high":-9.149163,"avg":-11.68467,"sd":1.364065,"marketCap":1287945033},"quantilePoints":[{"date":"2026-05-08","current":-10.976498,"twenty":-12.440976,"median":-11.330579,"eighty":-11.259763,"marketCap":821931163},{"date":"2026-05-15","current":-11.99625,"twenty":-12.004748,"median":-11.348283,"eighty":-11.231436,"marketCap":898291219},{"date":"2026-05-22","current":-12.173291,"twenty":-12.004748,"median":-11.330579,"eighty":-11.135126,"marketCap":911548174},{"date":"2026-05-29","current":-13.31343,"twenty":-12.537286,"median":-11.684659,"eighty":-11.163453,"marketCap":996922959},{"date":"2026-06-05","current":-12.661922,"twenty":-12.698746,"median":-12.017495,"eighty":-11.247016,"marketCap":948137367},{"date":"2026-06-12","current":-12.548616,"twenty":-12.593938,"median":-12.03874,"eighty":-11.316416,"marketCap":939652917},{"date":"2026-06-18","current":-10.501726,"twenty":-12.6166,"median":-12.03874,"eighty":-11.222938,"marketCap":915372405},{"date":"2026-06-26","current":-11.889673,"twenty":-12.53162,"median":-11.895161,"eighty":-11.165224,"marketCap":1036351448},{"date":"2026-07-02","current":-13.173217,"twenty":-12.752567,"median":-12.017495,"eighty":-11.198861,"marketCap":1148230297},{"date":"2026-07-10","current":-12.595929,"twenty":-12.752567,"median":-12.03874,"eighty":-11.215593,"marketCap":1097911580},{"date":"2026-07-17","current":-11.987935,"twenty":-12.752567,"median":-12.12726,"eighty":-11.302253,"marketCap":1044916336},{"date":"2026-07-24","current":-13.474144,"twenty":-12.866109,"median":-12.187454,"eighty":-11.330579,"marketCap":1174460267},{"date":"2026-07-31","current":-12.479243,"twenty":-12.804736,"median":-12.201617,"eighty":-11.330579,"marketCap":1087740776},{"date":"2026-08-07","current":-14.1804,"twenty":-12.896856,"median":-12.347233,"eighty":-11.365987,"marketCap":1236020399},{"date":"2026-08-14","current":-9.423399,"twenty":-12.896856,"median":-12.221306,"eighty":-11.295171,"marketCap":1269209340},{"date":"2026-08-21","current":-9.552568,"twenty":-12.881452,"median":-12.180373,"eighty":-11.146457,"marketCap":1286606769},{"date":"2026-08-28","current":-10.432907,"twenty":-12.804736,"median":-12.123719,"eighty":-11.036024,"marketCap":1405176937},{"date":"2026-09-04","current":-9.653917,"twenty":-12.782309,"median":-12.017495,"eighty":-10.432907,"marketCap":1300257059},{"date":"2026-09-09","current":-9.562504,"twenty":-12.770979,"median":-11.992093,"eighty":-9.888409,"marketCap":1287945033}],"updateTime":1789038017170},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2656337346","title":"Seaport Therapeutics Q2 EPS $(1.78) Misses $(0.65) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2656337346","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656337346?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:05","pubTimestamp":1785755116,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics (NASDAQ:SPTX) reported quarterly losses of $(1.78) per share which missed the analyst consensus estimate of $(0.65) by 173.85 percent. This is a 72.19 percent increase over losses of $(6.40) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60867629/seaport-therapeutics-q2-eps-1-78-misses-0-65-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656571373","title":"Seaport Therapeutics Q2 FY26 Net Loss Widens to $62.6 Million; R&D Expenses Rise to $24.62 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656571373","media":"Reuters","labels":["executive","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656571373?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:00","pubTimestamp":1785754842,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics Q2 FY26 net loss widens to $62.6 million; R&D expenses rise to $24.62 millionSeaport Therapeutics posted a Q2 2026 net loss of USD 62.6 million, widening from USD 15.1 million a y","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL3pblhQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656543373","title":"Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2656543373","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656543373?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:00","pubTimestamp":1785754801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUA33FR3M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651345211","title":"Seaport Therapeutics Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2651345211","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651345211?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:51","pubTimestamp":1784112660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SPTX/analyst-ratings(END) Dow Jones NewswiresJuly 15, 2026 06:51 ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451223","title":"Seaport Therapeutics, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451223?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:04","pubTimestamp":1784109841,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nAZN4T7XXX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651648525","title":"Seaport Therapeutics participates in a conference call with JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2651648525","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651648525?lang=en_us&edition=fundamental","pubTime":"2026-07-15 02:50","pubTimestamp":1784055022,"startTime":"0","endTime":"0","summary":"JPMorgan holds a conference call with management on July 14 at 3 pm. Webcast Link Published first on TheFly – the ultimate source for real-time, ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-participates-in-a-conference-call-with-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-participates-in-a-conference-call-with-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2430703095.HKD","JPM","LU1363072403.SGD","LU2054465674.USD","BK4516","LU1720051108.HKD","IE00BJTD4N35.SGD","JPX","LU0859254822.USD","LU2357627491.SGD","LU0417517546.SGD","IYG","LU1670628061.USD","FTXO","IE00B1BXHZ80.USD","JPO","LU1116320737.USD","LU0149725797.USD","LU1496350171.SGD","LU2242649171.HKD","PGF","UYG","SG9999002224.SGD","IE00BYXW3230.USD","LU0238689110.USD","VFH","KBWB","LU1988902786.USD","LU0310799852.SGD","LU2106854487.HKD","IE00BN8TJ469.HKD","FNCL","LU1116320901.HKD","LU0234572021.USD","LU2236285917.USD","SPTX","XLF","JPMO","IE0034235188.USD","LU2237443622.USD","IE00B775SV38.USD","LU1548497426.USD","IYF","LU1551013425.SGD","LU2552382058.USD","LU2211815571.USD","LU2505996681.GBP","LU0211328371.USD","LU2381873111.SGD","IXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646823822","title":"Top Insider Just Boosted Stake in Seaport Therapeutics With a Bold Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2646823822","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646823822?lang=en_us&edition=fundamental","pubTime":"2026-06-25 10:04","pubTimestamp":1782353050,"startTime":"0","endTime":"0","summary":"New insider activity at Seaport Therapeutics, Inc. ( ($SPTX) ) has taken place on June 24, 2026. Director Robert Hombach has increased his stake in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-insider-just-boosted-stake-in-seaport-therapeutics-with-a-bold-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-insider-just-boosted-stake-in-seaport-therapeutics-with-a-bold-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645463891","title":"Seaport Therapeutics Director Robert J. Hombach Trust Buys 13,000 Shares Worth $235,768","url":"https://stock-news.laohu8.com/highlight/detail?id=2645463891","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645463891?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:05","pubTimestamp":1782295548,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics director Robert J. Hombach trust buys 13,000 shares worth $235,768Seaport Therapeutics director Robert J. Hombach reported an indirect purchase of 13,000 common shares.The shares ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL752g0n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Seaport Therapeutics Director Robert J. Hombach Trust Buys 13,000 Shares Worth $235,768","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642249886","title":"Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642249886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642249886?lang=en_us&edition=fundamental","pubTime":"2026-06-09 21:01","pubTimestamp":1781010094,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Alamar Biosciences, Inc. (ALMR) and Seaport Therapeutics, In...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-alamar-biosciences-inc-almr-seaport-therapeutics-inc-sptx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-alamar-biosciences-inc-almr-seaport-therapeutics-inc-sptx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BLSG","BK4112","NA","BLSH","SPTX","BLSX","BK4007","BK4141","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641194489","title":"Seaport Therapeutics Q1 Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2641194489","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641194489?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:32","pubTimestamp":1780918324,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics  reported Monday its Q1 net loss widened to $10.34 per diluted share, compared with a loss of $5.65 a year earlier.Two analysts polled by FactSet expected a loss of $10.64.Cash, cash equivalents, and investments totaled $212.6 million as of March 31, which along with its initial public offering proceeds are expected to fund operations into 2029, the company said. Seaport said it raised $260 million in gross proceeds from its IPO in May.Shares of Seaport were up 3.8% in premarket activity Monday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641489546","title":"Seaport Therapeutics Q1 EPS $(10.34) Misses $(9.48) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2641489546","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641489546?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:22","pubTimestamp":1780917762,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics (NASDAQ:SPTX) reported quarterly losses of $(10.34) per share which missed the analyst consensus estimate of $(9.48) by 9.07 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/06/53053637/seaport-therapeutics-q1-eps-10-34-misses-9-48-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641374489","title":"Seaport Therapeutics reports Q1 EPS ($10.34) vs. ($5.65) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2641374489","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641374489?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:18","pubTimestamp":1780917532,"startTime":"0","endTime":"0","summary":"“The first quarter of 2026 was filled with meaningful progress for Seaport, and we significantly advanced the clinical development of our lead Glyp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-reports-q1-eps-10-34-vs-5-65-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-reports-q1-eps-10-34-vs-5-65-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641489568","title":"Seaport Therapeutics sees cash runway into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2641489568","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641489568?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:17","pubTimestamp":1780917470,"startTime":"0","endTime":"0","summary":"Cash, cash equivalents, and investments totaled $212.6 million as of March 31, 2026. Subsequent to March 31, 2026, Seaport completed its IPO, in wh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-sees-cash-runway-into-2029-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-sees-cash-runway-into-2029-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPTX","IPOS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486206","title":"Earnings Flash (SPTX) Seaport Therapeutics Posts Q1 Net Loss $10.34 a Share, vs. FactSet Est of $10.64 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486206","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486206?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:09","pubTimestamp":1780916971,"startTime":"0","endTime":"0","summary":"Earnings Flash (SPTX) Seaport Therapeutics Posts Q1 Net Loss $10.34 a Share, vs. FactSet Est of $10.64 Loss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641864744","title":"Seaport Therapeutics - Q1 Net Loss per Share $10.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2641864744","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641864744?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:05","pubTimestamp":1780916700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA2FRLJF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641861724","title":"Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2641861724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641861724?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:05","pubTimestamp":1780916700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA2FRLJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641609486","title":"Seaport Therapeutics - Seven-Day Glyphago Dosing Achieves Therapeutic Agomelatine Exposures Without Liver Enzyme Elevations","url":"https://stock-news.laohu8.com/highlight/detail?id=2641609486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641609486?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA7QNNCD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486953","title":"Seaport Therapeutics - to Initiate Phase 2B Glyphago Trial in First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486953?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA7QNNCD:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486939","title":"Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data From Phase 1 Proof-of-Concept Trial of Glyphago™ in Healthy Volunteers","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486939?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA7QNNCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486675","title":"Seaport Therapeutics - Repeat Dosing of Glyphago Shows Favorable Safety and No Liver-Related Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486675?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA7QNNCD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":59,"code":"91000000","status":"200"}]}}